Johnson & Johnson’s appeal on an earlier jury decision has been rejected, and the company has been ordered to pay the $8.3 million verdict issued in the DePuy hip replacement lawsuit it faced in March. Other companies facing hip lawsuits include BioMet for its M2a Magnum hip replacement.
DePuy issued a hip replacement recall in 2010 after studies showed the ASR hip replacements were failing at a rate much higher than expected, similar to the current BioMet model. A jury reached the $8.3 million verdict in March, determining that the DePuy ASR hip replacement was defectively designed.
A 2011 study of the BioMet M2a Magnum metal-on-metal hip replacement found that 7.2% of patients who received the implant required revision surgery to fix hip replacement side effects within the first year. The Food and Drug Administration has not issued a BioMet recall, though several BioMet lawsuits have been filed alleging the replacements caused severe injuries.